# A Phase I/II Study of Radiation Therapy, Paclitaxel Poliglumex and Cetuximab in Advanced Head and Neck Cancer

> **NCT00660218** · PHASE1,PHASE2 · COMPLETED · sponsor: **State University of New York - Upstate Medical University** · enrollment: 53 (actual)

## Conditions studied

- Carcinoma, Squamous Cell

## Interventions

- **DRUG:** paclitaxel poliglumex
- **BIOLOGICAL:** cetuximab
- **RADIATION:** radiation therapy (IMRT or 3D-CRT)

## Key facts

- **NCT ID:** NCT00660218
- **Lead sponsor:** State University of New York - Upstate Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2016-12
- **Final completion:** 2017-04
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2021-11-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00660218

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00660218, "A Phase I/II Study of Radiation Therapy, Paclitaxel Poliglumex and Cetuximab in Advanced Head and Neck Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00660218. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*